| Line Item | 2025-11-02 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $964.5M | +12.0% | +16.0% |
| Cost of Revenue | $267.1M | +4.1% | +7.6% |
| Gross Profit | $697.4M | +15.4% | +19.6% |
| R&D Expense | $256.4M | +5.9% | +28.1% |
| SG&A Expense | $93.3M | +30.4% | +38.6% |
| Operating Income | $53.9M | +1006.9% | -9.7% |
| Pre-tax Income | $65.7M | +29.9% | -14.5% |
| Income Tax | $10.9M | +215.7% | -17.4% |
| Net Income | $54.8M | +16.3% | -13.9% |
| EPS (Basic) | $0.17 | +21.4% | -10.5% |
| EPS (Diluted) | $0.16 | +14.3% | -15.8% |
| Line Item | 2025-11-02 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $852.8M | -3.9% | -4.7% |
| Accounts Receivable | $621.0M | +17.1% | +7.4% |
| Inventory | $82.4M | +76.1% | +98.3% |
| Current Assets | $2.65B | +5.1% | +3.6% |
| Total Assets | $4.22B | +4.8% | +9.4% |
| Current Liabilities | $1.61B |
| Line Item | 2025-11-02 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $612.1M | — | — |
| Capital Expenditures | $197.8M | — | — |
| Investing Cash Flow | -$25.8M | — | — |
| Financing Cash Flow | -$450.0M | — | — |
| Free Cash Flow | $414.3M | — | — |
| +11.1% |
| Total Liabilities | $2.82B | +4.0% | +15.2% |
| Stockholders' Equity | $1.40B | +6.4% | -0.5% |